<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Am J Respir Crit Care Med</journal-id>
<journal-id journal-id-type="iso-abbrev">Am. J. Respir. Crit. Care Med</journal-id>
<journal-id journal-id-type="publisher-id">ajrccm</journal-id>
<journal-title-group>
<journal-title>American Journal of Respiratory and Critical Care Medicine</journal-title>
</journal-title-group>
<issn pub-type="ppub">1073-449X</issn>
<issn pub-type="epub">1535-4970</issn>
<publisher>
<publisher-name>American Thoracic Society</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">26926454</article-id>
<article-id pub-id-type="pmc">5003329</article-id>
<article-id pub-id-type="publisher-manuscript">201508-1678OC</article-id>
<article-id pub-id-type="doi">10.1164/rccm.201508-1678OC</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Articles</subject>
<subj-group>
<subject>Pulmonary Vascular Disease</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Critical Genomic Networks and Vasoreactive Variants in Idiopathic Pulmonary Arterial Hypertension</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Hemnes</surname>
<given-names>Anna R.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhao</surname>
<given-names>Min</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>West</surname>
<given-names>James</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Newman</surname>
<given-names>John H.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rich</surname>
<given-names>Stuart</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Archer</surname>
<given-names>Stephen L.</given-names>
</name>
<xref ref-type="aff" rid="aff6">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Robbins</surname>
<given-names>Ivan M.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Blackwell</surname>
<given-names>Timothy S.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cogan</surname>
<given-names>Joy</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>5</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Loyd</surname>
<given-names>James E.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhao</surname>
<given-names>Zhongming</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gaskill</surname>
<given-names>Christa</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jetter</surname>
<given-names>Christopher</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kropski</surname>
<given-names>Jonathan A.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Majka</surname>
<given-names>Susan M.</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Austin</surname>
<given-names>Eric D.</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>6</sup>
</xref>
</contrib>
<aff id="aff1"><label><sup>1</sup></label>Division of Allergy, Pulmonary, and Critical Care Medicine</aff>
<aff id="aff2"><label><sup>2</sup></label>Department of Biomedical Informatics</aff>
<aff id="aff3"><label><sup>5</sup></label>Department of Pediatric Medical Genetics, and</aff>
<aff id="aff4"><label><sup>6</sup></label>Division of Allergy, Immunology, and Pulmonary Medicine, Department of Pediatrics, Vanderbilt University School of Medicine, Nashville, Tennessee</aff>
<aff id="aff5"><label><sup>3</sup></label>Division of Cardiology, University of Chicago, Chicago, Illinois; and</aff>
<aff id="aff6"><label><sup>4</sup></label>Department of Medicine, Queen’s University, Kingston, Ontario, Canada</aff>
</contrib-group>
<author-notes>
<corresp>Correspondence and requests for reprints should be addressed to Anna R. Hemnes, M.D., Division of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University School of Medicine, T1218 Medical Center North, 1161 21st Avenue South, Nashville, TN 37232. E-mail: <email xlink:href="anna.r.hemnes@vanderbilt.edu">anna.r.hemnes@vanderbilt.edu</email></corresp>
<fn id="fn1">
<label>*</label>
<p>Co–first authors.</p>
</fn>
</author-notes>
<pub-date pub-type="epub-ppub">
<day>15</day>
<month>8</month>
<year>2016</year>
<!--string-date: August 15, 2016-->
</pub-date>
<!--Fake epub and ppub dates generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' -->
<pub-date pub-type="epub">
<day>15</day>
<month>8</month>
<year>2016</year>
<!--string-date: August 15, 2016-->
</pub-date>
<pub-date pub-type="ppub">
<day>15</day>
<month>8</month>
<year>2016</year>
<!--string-date: August 15, 2016-->
</pub-date>
<volume>194</volume>
<issue>4</issue>
<fpage>464</fpage>
<lpage>475</lpage>
<history>
<date date-type="received">
<day>25</day>
<month>8</month>
<year>2015</year>
</date>
<date date-type="accepted">
<day>29</day>
<month>2</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2016 by the American Thoracic Society</copyright-statement>
<copyright-year>2016</copyright-year>
</permissions>
<self-uri content-type="pdf" xlink:href="rccm.201508-1678OC.pdf"></self-uri>
<related-article ext-link-type="doi" id="d38e325" related-article-type="companion" xlink:href="10.1164/rccm.201603-0577ED"></related-article>
<abstract>
<p><bold>Rationale:</bold> Idiopathic pulmonary arterial hypertension (IPAH) is usually without an identified genetic cause, despite clinical and molecular similarity to bone morphogenetic protein receptor type 2 mutation–associated heritable pulmonary arterial hypertension (PAH). There is phenotypic heterogeneity in IPAH, with a minority of patients showing long-term improvement with calcium channel–blocker therapy.</p>
<p><bold>Objectives:</bold> We sought to identify gene variants (GVs) underlying IPAH and determine whether GVs differ in vasodilator-responsive IPAH (VR-PAH) versus vasodilator-nonresponsive IPAH (VN-PAH).</p>
<p><bold>Methods:</bold> We performed whole-exome sequencing (WES) on 36 patients with IPAH: 17 with VR-PAH and 19 with VN-PAH. Wnt pathway differences were explored in human lung fibroblasts.</p>
<p><bold>Measurements and Main Results:</bold> We identified 1,369 genes with 1,580 variants unique to IPAH. We used a gene ontology approach to analyze variants and identified overrepresentation of several pathways, including cytoskeletal function and ion binding. By mapping WES data to prior genome-wide association study data, Wnt pathway genes were highlighted. Using the connectivity map to define genetic differences between VR-PAH and VN-PAH, we found enrichment in vascular smooth muscle cell contraction pathways and greater genetic variation in VR-PAH versus VN-PAH. Using human lung fibroblasts, we found increased stimulated Wnt activity in IPAH versus controls.</p>
<p><bold>Conclusions:</bold> A pathway-based analysis of WES data in IPAH demonstrated multiple rare GVs that converge on key biological pathways, such as cytoskeletal function and Wnt signaling pathway. Vascular smooth muscle contraction–related genes were enriched in VR-PAH, suggesting a potentially different genetic predisposition for VR-PAH. This pathway-based approach may be applied to next-generation sequencing data in other diseases to uncover the contribution of unexpected or multiple GVs to a phenotype.</p>
</abstract>
<kwd-group>
<title>Keywords</title>
<kwd>whole-exome sequencing</kwd>
<kwd>pulmonary arterial hypertension</kwd>
<kwd>vasodilator responsive</kwd>
</kwd-group>
<counts>
<fig-count count="6"></fig-count>
<table-count count="3"></table-count>
<page-count count="12"></page-count>
</counts>
</article-meta>
</front>
</article>
</pmc-articleset>